Scientists test new nasal spray vaccine against COVID-19
NCT ID NCT06026514
Summary
This early-stage study tested a new type of COVID-19 vaccine given as a nasal spray. Researchers enrolled 27 healthy adults aged 18-50 to receive two doses of the experimental vaccine, 56 days apart. The main goals were to check if the vaccine was safe and whether it triggered an immune response against the virus.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV-2 INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins Bloomberg School of Public Health
Baltimore, Maryland, 20215, United States
Conditions
Explore the condition pages connected to this study.